Archive for October 8, 2019
Biotechnology Innovation Organization Announces 2021 Leadership Transition
The Biotechnology Innovation Organization (BIO) today announced that industry veteran Jim Greenwood will step down as President and CEO of the world’s largest biotechnology organization after the 2020 election and help transition a new leader to represent the industry globally and to defend innovation from domestic political attacks. Biotechnology Innovation Organization Announces 2021 Leadership Transition…
Read MoreIntent Solutions Joins University of Kentucky Program to Eliminate Hepatitis C in Appalachia
ATLANTA, Ga., July 8, 2019 /PRNewswire/ — Intent Solutions, an Atlanta-based company that provides technology to improve prescription drug safety and adherence, announced today that it is partnering with the University of Kentuckyin a $15 million federal grant program aimed at eliminating Hepatitis C in one eastern Kentucky county hardest hit by the disease. Intent Solutions recently signed a contract with the University of Kentucky to…
Read MoreGeorgia Bio Members Take Advantage of the Abundant Networking and Partnering Opportunities at BIO 2019
Georgia Bio and some of its members had the opportunity to continue their mission of advancing the growth of Georgia’s life science industry.
Read MoreVideo interview: Georgia’s Innovation Crescent fosters collaboration for a strong Life Sciences Ecosystem
Georgia’s Innovation Crescent is both a geographic region and an economic development partnership of more than 15 counties and economic development entities all dedicated to supporting Georgia’s life science and technology growth. We asked Kristin Boscan, Executive Director, Innovation Crescent Regional Partnership her take on the state of life sciences industry in Georgia and how…
Read MoreAlpharetta biopharma company names board member as interim CEO
An Alpharetta company that is working on treatments for eye disease patients has named a member of its board of directors as interim CEO. George Lasezkay succeeds Daniel H. White as chief executive of Clearside Biomedical Inc. (NASDAQ: CLSD). White resigned as president, CEO and as a member of the Clearside board to pursue other…
Read MoreWhat are the most exciting opportunities in cardiovascular innovation? Part 2 of our interview with Dr. Richard Hillstead
Strokes and cardiovascular disease are taking far too many lives says Dr. Richard Hillstead. These medical issues are ripe for innovation, particularly in minimally invasive opportunities that shorten or eliminate hospital stays while improving patient outcomes. And what about genomics? “I question whether we are as morally and ethically advanced as we are scientifically and…
Read MoreWhat are the top things new life science innovators need to know? Decorated cardiology researcher and innovator Dr. Richard Hillstead tells us.
Dr. Richard Hillstead is both a medtech innovator and a fellow in the American Heart Association on the Council of Clinical Cardiology. He has practiced on the front lines of patient care and life science innovation for decades. Dr. Hillstead, a recipient of a 2019 Industry Growth Award, Georgia Bio’s highest honor, spoke with Write2Market…
Read More